BioSpace News Archive

Kincell Bio today emerged from stealth with $36 million in new funding. Kineticos Ventures led Kincell’s launch funding.

PolyPid Ltd. today announced that it will report its second quarter 2023 financial results and operational highlights before the open of the U.S. financial markets on Wednesday, August 9, 2023.

Karyopharm Therapeutics Inc. today announced it will report second quarter 2023 financial results on Wednesday, August 2, 2023.

Veeva Systems revealed findings of field medical’s impact on clinical practice in the Veeva Pulse Field Trends Report.

Children’s Hospital Colorado announced the launch of the Precision Medicine Institute, which will allow experts to more efficiently integrate precision medicine into care provided to patients throughout the hospital.

Nephros, Inc. today announced that it will file its second-quarter financial results on Wednesday, August 9, 2023 after market close and will host a conference call that same day at 4:30pm ET.

Accuray Incorporated (NASDAQ: ARAY) will report financial results for the fourth quarter and fiscal year 2023, ended June 30, 2023, during a conference call hosted by company management at 1:30 p.m. PT / 4:30 p.m. ET on August 9, 2023.

Inozyme Pharma, Inc. today announced a regulatory update for its global development strategy of INZ-701 for the treatment of ENPP1 Deficiency following recent meetings with the United States (U.S.) Food and Drug Administration (FDA) and the Paediatric Committee (PDCO) of the European Medicines Agency (EMA).

Immuno-oncology leader, Agenus (Nasdaq: AGEN), today announced the Company will release its second quarter 2023 financial results via press release before the market opens on Tuesday, August 8, 2023.

Oculis Holding AG today announced that it will participate at the following upcoming investor conferences.